<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
      <channel>
        <title>Latest articles from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com</link>
        <description>
          Latest articles from Medical Marketing and Media
        </description>
  
        <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/MMMHome" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
          <title>Day Two in DC: Can we police everything online?</title>
          <description>If day two of FDA's hearings on Internet promotion of drugs had a totem animal, it would be the ostrich. The birds, heads buried, adorned many a slide designed to hammer home the point that many companies are so fearful of violating adverse events reporting requirements that they go out of their way not to monitor the Internet for reports.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/XXxuwIEKv4q8uRTfmlxnF5PqXd8/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XXxuwIEKv4q8uRTfmlxnF5PqXd8/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/XXxuwIEKv4q8uRTfmlxnF5PqXd8/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XXxuwIEKv4q8uRTfmlxnF5PqXd8/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/bVzsIZuir5o" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/bVzsIZuir5o/</link>
          <pubDate>Fri, 13 Nov 2009 19:18:13 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Day-Two-in-DC-Can-we-police-everything-online/article/157753/</feedburner:origLink></item>
  
        <item>
          <title>Day One in DC: Industry bends FDA's ear on social media</title>
          <description>The FDA's hearings on promotion of regulated products online and using social media—the "Super Bowl of Part 15 Hearings," as Porter Novelli's Peter Pitts dubbed them—got under way yesterday in a near-capacity federal conference hall.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/2MHvwg33h7006vpaPm9OkXULTak/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/2MHvwg33h7006vpaPm9OkXULTak/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/2MHvwg33h7006vpaPm9OkXULTak/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/2MHvwg33h7006vpaPm9OkXULTak/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/yKC1hhe6lZc" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/yKC1hhe6lZc/</link>
          <pubDate>Fri, 13 Nov 2009 08:07:29 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Day-One-in-DC-Industry-bends-FDAs-ear-on-social-media/article/157700/</feedburner:origLink></item>
  
        <item>
          <title>ACCME ponders naming and shaming</title>
          <description>The ACCME said it will consider releasing names of providers and activities found to violate bias rules. The exact details of the disclosure, if any, and the timing are under review by the ACCME Board of Directors, which meets December 3-4.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/XIGe-ZpxtLKw4fRlo5YYn36pX4Y/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XIGe-ZpxtLKw4fRlo5YYn36pX4Y/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/XIGe-ZpxtLKw4fRlo5YYn36pX4Y/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XIGe-ZpxtLKw4fRlo5YYn36pX4Y/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/GcBxQI8mch4" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/GcBxQI8mch4/</link>
          <pubDate>Thu, 12 Nov 2009 13:22:18 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/ACCME-ponders-naming-and-shaming/article/157649/</feedburner:origLink></item>
  
        <item>
          <title>FDA seeks input on social media regulation</title>
          <description>Will the FDA hearings on social media, which kicked off today, result in guidance specific to online media? That's the question on the minds of digital gurus converging on the capitol for two days of presentations on using social media in drug and device marketing.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/8qTgKLiSN8s-HlEVe7Xv5Ffx9jY/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/8qTgKLiSN8s-HlEVe7Xv5Ffx9jY/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/8qTgKLiSN8s-HlEVe7Xv5Ffx9jY/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/8qTgKLiSN8s-HlEVe7Xv5Ffx9jY/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/AJ6TpB5K_gw" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/AJ6TpB5K_gw/</link>
          <pubDate>Thu, 12 Nov 2009 12:59:15 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/FDA-seeks-input-on-social-media-regulation/article/157646/</feedburner:origLink></item>
  
        <item>
          <title>Drugs.com defects to WebMD</title>
          <description>Drugs.com, a free online drug-information database, will join the WebMD Health Network starting Jan. 1, said WebMD.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/JzUlxCdyoMOcdPr0VkJWp07rOlI/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JzUlxCdyoMOcdPr0VkJWp07rOlI/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/JzUlxCdyoMOcdPr0VkJWp07rOlI/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JzUlxCdyoMOcdPr0VkJWp07rOlI/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/zZEs2WXxyIY" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/zZEs2WXxyIY/</link>
          <pubDate>Wed, 11 Nov 2009 15:40:44 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Drugscom-defects-to-WebMD/article/157593/</feedburner:origLink></item>
  
        <item>
          <title>Bid to restrict industry-backed CME rebuffed, again</title>
          <description>A third attempt by an AMA ethics council asking physicians and medical institutions to curb industry funding for professional educational activities was rebuffed yesterday.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/VWNKNkCEELOYlpk2NhqCOwokekg/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/VWNKNkCEELOYlpk2NhqCOwokekg/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/VWNKNkCEELOYlpk2NhqCOwokekg/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/VWNKNkCEELOYlpk2NhqCOwokekg/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/_cDNxlrNquo" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/_cDNxlrNquo/</link>
          <pubDate>Tue, 10 Nov 2009 15:18:11 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Bid-to-restrict-industry-backed-CME-rebuffed-again/article/157524/</feedburner:origLink></item>
  
        <item>
          <title>Pfizer shrinks R&amp;D operations</title>
          <description>Pfizer will shrink the square footage of its global R&amp;D operation by 35% as it absorbs Wyeth, sharply reducing some sites, shuttering others and prompting an as-yet unspecified number of layoffs.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/YTv0WMuWWHJaRVlHigw5KBFpL3M/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/YTv0WMuWWHJaRVlHigw5KBFpL3M/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/YTv0WMuWWHJaRVlHigw5KBFpL3M/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/YTv0WMuWWHJaRVlHigw5KBFpL3M/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/vPIqEMnBOYU" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/vPIqEMnBOYU/</link>
          <pubDate>Mon, 09 Nov 2009 14:44:54 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Pfizer-shrinks-RD-operations/article/157434/</feedburner:origLink></item>
  
        <item>
          <title>PhRMA: use FDA logo for link to PI, patient info online</title>
          <description>PhRMA called for FDA to develop an agency icon or bug that drugmakers could use on their websites to link to agency-approved product information and patient medical guides.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/0mf-HT4BYUY5ictiTiXnmiJ0PCU/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/0mf-HT4BYUY5ictiTiXnmiJ0PCU/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/0mf-HT4BYUY5ictiTiXnmiJ0PCU/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/0mf-HT4BYUY5ictiTiXnmiJ0PCU/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/J-_7yK7_irg" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/J-_7yK7_irg/</link>
          <pubDate>Mon, 09 Nov 2009 13:17:33 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/PhRMA-use-FDA-logo-for-link-to-PI-patient-info-online/article/157414/</feedburner:origLink></item>
  
        <item>
          <title>EMD Serono film contest flags infertility</title>
          <description>EMD Serono extended its "In the Know" infertility awareness effort with a short film festival, inviting couples who've struggled with infertility to submit 5-8 minute videos about their experiences.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/FeMcsrEqMvwads1kiRLsm5SdA40/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/FeMcsrEqMvwads1kiRLsm5SdA40/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/FeMcsrEqMvwads1kiRLsm5SdA40/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/FeMcsrEqMvwads1kiRLsm5SdA40/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/rPPSVob5ohk" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/rPPSVob5ohk/</link>
          <pubDate>Mon, 09 Nov 2009 11:26:30 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/EMD-Serono-film-contest-flags-infertility/article/157387/</feedburner:origLink></item>
  
        <item>
          <title>IMS Health purchased for $5.2 billion</title>
          <description>Marketing research giant IMS Health will be acquired by private equity firm TPG Capital and the Canadian Pension Plan Investment Board, a Toronto-based investment management organization, for $5.2 billion.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/UOINjyqooCtVCcyBXAK_KTMwXOY/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/UOINjyqooCtVCcyBXAK_KTMwXOY/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/UOINjyqooCtVCcyBXAK_KTMwXOY/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/UOINjyqooCtVCcyBXAK_KTMwXOY/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/JGr8mgDhBz4" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/JGr8mgDhBz4/</link>
          <pubDate>Fri, 06 Nov 2009 11:59:52 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/IMS-Health-purchased-for-52-billion/article/157250/</feedburner:origLink></item>
  
        <item>
          <title>Sales Force Report: The Online Rep</title>
          <description>How Millennium: The Takeda Oncology Company, Pfizer and others are turning to the web to better train sales reps and get more "face" time with physicians.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/H0ucYl0kF6Qv-0BO0t79sQGtqsA/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/H0ucYl0kF6Qv-0BO0t79sQGtqsA/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/H0ucYl0kF6Qv-0BO0t79sQGtqsA/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/H0ucYl0kF6Qv-0BO0t79sQGtqsA/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/C3MtlmeqmDE" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/C3MtlmeqmDE/</link>
          <pubDate>Sun, 01 Nov 2009 12:45:00 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Sales-Force-Report-The-Online-Rep/article/156638/</feedburner:origLink></item>
  
        <item>
          <title>An Orphan's Tale</title>
          <description>When your patient population is just 10,000, the pharma marketing rulebook goes out of the window. Ben Comer examines one of the most successful ultra orphan campaigns of all time
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/_JtHEpn2eg7aV1jQ1hpWW4H1TAI/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/_JtHEpn2eg7aV1jQ1hpWW4H1TAI/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/_JtHEpn2eg7aV1jQ1hpWW4H1TAI/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/_JtHEpn2eg7aV1jQ1hpWW4H1TAI/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/HqGRR81dkJU" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/HqGRR81dkJU/</link>
          <pubDate>Sun, 01 Nov 2009 12:54:00 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/An-Orphans-Tale/article/156639/</feedburner:origLink></item>
  
        <item>
          <title>Social Standards</title>
          <description>With FDA set to hold its first public hearings on Internet promotion in 13 years, Matthew Arnold looks at the key questions and what might come out of it
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/5YVFq4pDJEJ9fSwYGdtGpYdyoJQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/5YVFq4pDJEJ9fSwYGdtGpYdyoJQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/5YVFq4pDJEJ9fSwYGdtGpYdyoJQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/5YVFq4pDJEJ9fSwYGdtGpYdyoJQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/Rt7wlInFp9g" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/Rt7wlInFp9g/</link>
          <pubDate>Sun, 01 Nov 2009 12:57:00 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Social-Standards/article/156640/</feedburner:origLink></item>
  
        <item>
          <title>Headliner: NPR's Scott Hensley</title>
          <description>Scott Hensley is a little like digital health journalism's Johnny Appleseed. Having served as the founding editor of the Wall Street Journal Health Blog, Hensley left the Journal last spring and in August joined National Public Radio, where he serves as a digital correspondent, editor and main writer on--surprise!--the NPR Health Blog.
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/puPk3EVBYbyRYZhBtuFXqVqQ4ik/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/puPk3EVBYbyRYZhBtuFXqVqQ4ik/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/puPk3EVBYbyRYZhBtuFXqVqQ4ik/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/puPk3EVBYbyRYZhBtuFXqVqQ4ik/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/MMMHome/~4/K0cu2XqmGY4" height="1" width="1"/&gt;</description>
          <link>http://feedproxy.google.com/~r/MMMHome/~3/K0cu2XqmGY4/</link>
          <pubDate>Sun, 01 Nov 2009 00:00:00 GMT</pubDate>
        <feedburner:origLink>http://www.mmm-online.com/Headliner-NPRs-Scott-Hensley/article/156664/</feedburner:origLink></item>
  
      </channel>
    </rss>
